Evaluation of lymphangiogenic factors, vascular endothelial growth factor D and E-cadherin in distinguishing inflammatory from locally advanced breast cancer

Authors

Paul H. Levine, George Washington UniversityFollow
Chia C. Portera, National Cancer Institute, Bethesda, MD
Heather J. Hoffman, George Washington UniversityFollow
Sherry X. Yang, National Cancer Institute, Bethesda, MD
Mikiko Takikita, National Cancer Institute, Bethesda, MD
Quyen N. Duong, George Washington University
Stephen M. Hewitt, National Cancer Institute, Bethesda, MD
Sandra M. Swain, Medstar Washington Hospital Center, Washington, DCFollow

Document Type

Journal Article

Publication Date

8-2012

Journal

Clinical Breast Cancer

Volume

Volume 12, Issue 4

Inclusive Pages

232-239

Keywords

Inflammatory Breast Neoplasms--metabolism; Inflammatory Breast Neoplasms--pathology; Lymphatic Vessels--pathology; Receptor; erbB-2--metabolism; Tumor Markers; Biological--metabolism; Vascular Endothelial Growth Factor D--metabolism

APA Citation

Levine, P. H., Portera, C. C., Hoffman, H. J., Yang, S. X., Takikita, M., Duong, Q. N., Hewitt, S.M., Swain, S. M. (2012). Evaluation of lymphangiogenic factors, vascular endothelial growth factor D and E-cadherin in distinguishing inflammatory from locally advanced breast cancer. Clinical Breast Cancer, 12(4), 232-239.

Peer Reviewed

1